Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01UVU
|
||||
Former ID |
DNC014890
|
||||
Drug Name |
4-(3-bromopyrazolo[1,5-a]pyrimidin-6-yl)phenol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [531199] | ||
Structure |
Download2D MOL |
||||
Formula |
C12H8BrN3O
|
||||
Canonical SMILES |
C1=CC(=CC=C1C2=CN3C(=C(C=N3)Br)N=C2)O
|
||||
InChI |
1S/C12H8BrN3O/c13-11-6-15-16-7-9(5-14-12(11)16)8-1-3-10(17)4-2-8/h1-7,17H
|
||||
InChIKey |
XBHIAJWNXVJSAA-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | AMP-activated protein kinase | Target Info | Inhibitor | [531199] | |
KEGG Pathway | FoxO signaling pathway | ||||
Regulation of autophagy | |||||
mTOR signaling pathway | |||||
PI3K-Akt signaling pathway | |||||
AMPK signaling pathway | |||||
Circadian rhythm | |||||
Insulin signaling pathway | |||||
Adipocytokine signaling pathway | |||||
Oxytocin signaling pathway | |||||
Glucagon signaling pathway | |||||
Non-alcoholic fatty liver disease (NAFLD) | |||||
Hypertrophic cardiomyopathy (HCM) | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.